Drug class
Inorganic heavy-metal active moiety; gastrointestinal mucosal protectant and antimicrobial component of bismuth salts
Mechanism of action
Bismuth compounds exert local gastrointestinal effects through mucosal coating and binding to bacterial proteins and toxins. Certain bismuth salts also have antimicrobial activity against Helicobacter pylori and other enteric organisms; the exact mechanism and use depend on the specific salt and formulation.
General use cases
- Symptomatic relief of diarrhoea and dyspepsia with authorised bismuth subsalicylate products
- Component of specific combination regimens for Helicobacter pylori eradication, such as bismuth quadruple therapy; do not assign these indications to all bismuth compounds or formulations
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
